Skip to main content
. 2022 Jun 24;14(13):2613. doi: 10.3390/nu14132613

Table 2.

OR and 95%CIs of serum spermidine levels for obesity (BMI ≥ 28 kg/m2) and overweight/obesity (BMI ≥ 24 kg/m2) in the cross-sectional study.

Serum Spermidine
Q1 Q2 Q3 Q4
OR OR (95% CI) p-Value OR (95% CI) p-Value OR (95% CI) p-Value
Obesity
Model 1 1.000 (Ref.) 1.009 (0.799, 1.275) 0.938 1.254 (1.001, 1.572) 0.049 1.307 (1.044, 1.636) 0.019
Model 2 1.000 (Ref.) 0.992 (0.785, 1.254) 0.946 1.263 (1.007, 1.584) 0.044 1.375 (1.096, 1.725) 0.006
Model 3 1.000 (Ref.) 0.993 (0.780, 1.264) 0.953 1.327 (1.050, 1.678) 0.018 1.417 (1.121, 1.791) 0.004
Overweight/Obesity
Model 1 1.000 (Ref.) 1.096 (0.924, 1.301) 0.293 1.193 (1.005. 1.416) 0.044 1.312 (1.104, 1.559) 0.002
Model 2 1.000 (Ref.) 1.079 (0.909, 1.282) 0.385 1.200 (1.010, 1.426) 0.038 1.374 (1.154, 1.636) <0.001
Model 3 1.000 (Ref.) 1.106 (0.919, 1.330) 0.288 1.315 (1.092, 1.582) 0.004 1.449 (1.201, 1.748) <0.001

CI: indicates confidence interval; OR: odds ratio. Model 1: unadjusted. Model 2: adjusting gender and age. Model 3: adjusting gender, age, smoking, drinking, ethnicity, physical labor levels, fruit/vegetables intake levels, whole grain intake levels, triglyceride, HDL-C, LDL-C, total cholesterol, history of diabetes, history of stroke.